Table 1.
n | % | |
---|---|---|
Sex | ||
Women | 193 | 42.6 |
Men | 260 | 57.4 |
Age | ||
Mean ± SD | 68.1 ± 9.5 | |
Smoking status | ||
Never smoker | 179 | 59.5 |
Smoker | 274 | 60.5 |
Surgical procedure | ||
≥Lobectomy | 388 | 85.7 |
≤Segmentectomy | 65 | 14.3 |
Pathological stage | ||
I | 322 | 71.1 |
II | 60 | 13.2 |
III | 71 | 15.7 |
T factor | ||
T1 | 218 | 48.1 |
T2 | 194 | 42.8 |
T3 | 39 | 8.6 |
T4 | 2 | 0.4 |
N factor | ||
N0 | 348 | 76.8 |
N1 | 42 | 9.3 |
N2 | 63 | 13.9 |
Histology | ||
AC | 328 | 72.4 |
SQ | 107 | 23.6 |
Others | 18 | 4.0 |
MDM2 SNP309 | ||
TT | 94 | 20.8 |
TG | 220 | 48.6 |
GG | 139 | 30.7 |
Adjuvant chemotherapy | 123 | 27.2 |
Chemotherapy (postrecurrence) | 69 | 15.2 |
Radiation therapy (postrecurrence) | 51 | 11.3 |
Patients who had undergone preoperative therapies (chemotherapy and/or radiation therapy) and had a history of lung cancer were excluded. AC, adenocarcinoma; SQ, squamous cell carcinoma.